PAFSC 1st Committee to Discuss Add’l Indication for Cymbalta on April 28

April 15, 2015
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs, an advisory organ to the health minister, will discuss on April 28 whether to endorse approval of Shionogi’s antidepressant Cymbalta (duloxetine) for a new indication of fibromyalgia pain...read more